Validating AI Output in Patent Practice: Solve Intelligence at ABA-IPL 2026

The American Bar Association’s Intellectual Property Law Section Spring Conference (ABA-IPL) remains one of the premier annual gatherings for IP professionals, bringing together practitioners, in-house counsel, academics, and policymakers to explore the latest developments shaping the field. 

Solve Intelligence was invited not only to attend, but to share their expertise on the concluding panel as leaders in AI.

Validating AI Output in Patent Practice: Solve Intelligence at ABA-IPL 2026

Key insights

  • Generative tools produce probabilistic responses; even confident outputs can be wrong.
  • Every AI output needs review for hallucination, fabricated citations, and weak reasoning.
  • Document what you directed, what the model returned, and what you conceived independently.

Held in April 2026 in Washington, D.C., the conference featured a packed agenda of more than 20 Continuing Legal Education (CLE) sessions alongside networking events, keynote programming, and section business meetings. A central theme of this year’s conference was the rapid evolution of intellectual property law in response to emerging technologies, particularly artificial intelligence and data-driven innovation. 

One of these sessions was the hotly debated topic of AI at the intersection of IP and ethics. 

AI validation and ethics in patent practice

At this year's ABA-IPL "AI & Ethics Roundup," Chris Parsonson, CEO and co-founder of Solve Intelligence, joined Emil Ali (McCabe & Ali), Paul Morico (Baker Botts), and Tammy Pennington Rhodes (Supercharger AI) to discuss how patent practitioners should handle AI tool output across validity, infringement, and freedom-to-operate work.

Chris underscored two non-negotiables when integrating generative tools into any professional workflow:

Validate outputs thoroughly

Generative tools should not be taken just at face value. Instead, patent professionals should always confirm accuracy and independently verify any cited sources. Because these models generate responses probabilistically rather than retrieving information from a reliable database, even outputs that sound confident and authoritative can still be incorrect.

Apply critical, informed judgment

Every output should be reviewed for relevance, logical consistency, and overall credibility. This means actively looking for signs of hallucination, such as fabricated citations, claims that aren’t supported by the referenced material, or reasoning that doesn’t hold up under closer scrutiny.

USPTO guidance on AI-assisted inventorship

That same emphasis on human oversight ran through the panel's discussion of the November 2025 USPTO guidance on AI-assisted inventorship. The guidance treats AI systems as tools, analogous to lab equipment or research databases, and keeps conception as the touchstone: a natural person must possess the "definite and permanent idea of the complete and operative invention." 

A single human inventing with AI raises no joint inventorship question, since AI cannot be a joint inventor; when multiple humans collaborate using AI, the Pannu factors apply among the humans only. 

Relatedly, on the question of human inventorship, participants at the conference discussed the importance of having documentation to show what the human directed, what the model returned, and what the human conceived independently.

IP law in motion

Beyond substantive programming, IPLSPRING emphasized community and collaboration. Attendees had ample opportunities to connect through networking sessions, sponsor showcases, and social events, reinforcing the conference’s role as a hub for relationship-building across the IP ecosystem. 

Overall, the ABA-IPL Spring Conference underscored both the dynamism and complexity of modern intellectual property law.

AI for patents.

Be 50%+ more productive. Join thousands of legal professionals around the World using Solve’s Patent Copilot™ for drafting, prosecution, invention harvesting, and more.

Related articles

What Is a Freedom to Operate Analysis, and How Does AI Speed It Up?

A freedom to operate (FTO) analysis is a claim-by-claim assessment of whether a commercial activity would infringe any third-party patents in the markets where it will take place. AI speeds it up by handling the parts that scale badly by hand: surfacing relevant patents, mapping product features against claims element by element, pulling legal status by jurisdiction, and producing a cited, structured draft for the attorney to review and refine.

Key takeaways

•     FTO analysis determines whether a product infringes third-party patents.

•     A valid patent on your own invention doesn’t guarantee freedom to operate.

•     Purpose-built AI patent tools deliver around 60 to 90 percent efficiency gains on structured FTO tasks.

•     Generalist AI and purpose-built patent tools share a surface format; but FTO reliability depends on integration, not interface.

How to Build an Invalidity Claim Chart: A Practical Guide

An invalidity claim chart is a structured document that maps, for example, each limitation of a patent claim against prior art to show the patent should never have been granted. If you’re defending against infringement allegations, preparing an IPR petition, opposing a European patent, or advising a client on patent risk, knowing how to build one correctly is non-negotiable.

Key takeaways

•       A well-built invalidity chart maps every claim limitation to prior art, element by element, with pinpoint citations to the exact column, line, page, or figure.

•       When IPRs reach a final written decision, the PTAB now finds every challenged claim unpatentable around 70% of the time; and the chart is a key component of getting a petition instituted in the first place.

•       Solve Intelligence’s Charts generates fully cited, limitation-by-limitation invalidity charts in minutes rather than days, flags weak limitation coverage candidly, and lets attorneys inspect the reasoning behind every mapping.

LAC 2026: What Generic and Biosimilar IP Teams Think About AI

Generic and biosimilar IP teams are already using AI for prosecution history and FTO work. The live debate is not about adoption, but internal framing of quality and coverage extension without reducing headcount. The teams furthest along chose the former.

Key takeaways

  • Generic and biosimilar IP teams use AI primarily for prosecution history summaries, invalidity analysis and FTO claim charting.
  • Viewing AI as a quality and coverage extension drives durable internal adoption.
  • General-purpose AI cannot reliably interpret claim scope from prosecution history; patent-specific tools are required.

Aliza Panjwani Joins Solve

We’re happy to welcome Aliza Panjwani as a Legal & Product Engineer.